Nutra Pharma Corp
NPHC· OTC
NPHCNutra Pharma Corp
Filed Dec 5, 2012 · 10-Q · 66 days after period end · 0001144204-12-066556
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $13.22K | $251.83K | $359.94K |
| Net Income | -$302.78K | -$661.76K | -$640.74K |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Dec 5, 2012 · 66 d after period end
